The Biden administration will reopen the health exchanges created by the Affordable Care Act (ACA); direct HHS and other agencies to reexamine other health policies, including Medicaid work requirements; and reverse the so-called global gag rule while affirming support for reproductive health.
Using 2 executive orders Thursday, President Joe Biden reopened the health exchanges created by the Affordable Care Act (ACA), directed his administration to reexamine other health policies, including Medicaid work requirements, and reversed the so-called global gag rule while affirming support for reproductive health.
One order will reopen HealthCare.gov from February 15 to May 15, something health policy experts suggested the Trump administration do last year to cope with the loss of health insurance amid staggering job losses created by the coronavirus disease 2019 (COVID-19) pandemic.
In addition, the order directs agencies to review policies put in place during the Trump administration, including CMS Section 1115 demonstrations and waivers that encouraged states to implement work requirements as a condition for receiving health benefits through Medicaid. Advocates for low-income beneficiaries sued states that embraced the concept; in Arkansas and New Hampshire, lower courts ruled against the Trump administration, and the Supreme Court announced in late December 2020 it would hear appeals from the then-administration.
Other aspects of the order tell agencies to reexamine:
The second order, Protecting Women’s Health at Home and Abroad, will immediately rescind the global gag rule, also referred to as the Mexico City Policy, which bars international nonprofits that provide abortion counseling or referrals from receiving US funding. It also directs HHS to take immediate action to consider whether to rescind regulations under its Title X family planning program.
In the United States and globally, a statement from the Biden administration said, "women, Black, Indigenous and other people of color, LGBTQ+ people, and those with low incomes—have been denied access to reproductive health care."
Last year, for instance, a coalition of 23 states sued the Trump administration over an HHS rule that would end health care discrimination protections within the ACA for LGBTQ people, individuals with limited English proficiency, and women who have had abortions.
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More